[HTML][HTML] The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
The upcoming 5th edition of the World Health Organization (WHO) Classification of
Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in …
Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in …
Catalytic dehydrogenative cross-coupling: forming carbon− carbon bonds by oxidizing two carbon− hydrogen bonds
… complex with a M−C bond that can subsequently insert into C═C double bonds, yielding
an … , one C−C bond and two C−N bonds are formed at the expense of two C−H bonds, a C═C …
an … , one C−C bond and two C−N bonds are formed at the expense of two C−H bonds, a C═C …
Recommender systems
… The network clustering coefficient is defined as the average of c x over all x with k x > 1 . It is
… are c 2 = 1 6 , c 3 = c 4 = 0 , c 5 = 1 3 and c 6 = 1 , and the average clustering coefficient is C …
… are c 2 = 1 6 , c 3 = c 4 = 0 , c 5 = 1 3 and c 6 = 1 , and the average clustering coefficient is C …
Stacked nanosheet gate-all-around transistor to enable scaling beyond FinFET
In this paper, for the first time we demonstrate that horizontally stacked gate-all-around (GAA)
Nanosheet structure is a good candidate for the replacement of FinFET at the 5nm …
Nanosheet structure is a good candidate for the replacement of FinFET at the 5nm …
[PDF][PDF] CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer
…, CM Hatheway, BJ Abraham, B Sharma, C Yeung… - Cell, 2014 - cell.com
The MYC oncoproteins are thought to stimulate tumor cell growth and proliferation through
amplification of gene transcription, a mechanism that has thwarted most efforts to inhibit MYC …
amplification of gene transcription, a mechanism that has thwarted most efforts to inhibit MYC …
[HTML][HTML] CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
… C. Yeung receives unrelated research funding from Gilead Sciences. C. Berger receives
research funding from Juno Therapeutics. SR Riddell, M. …
research funding from Juno Therapeutics. SR Riddell, M. …
Effects of delayed versus immediate umbilical cord clamping in reducing death or major disability at 2 years corrected age among very preterm infants (APTS): a …
…, I Rieger, P Suresh, A Martin, C Yeung… - The Lancet Child & …, 2022 - thelancet.com
Background Very preterm infants are at increased risk of adverse outcomes in early childhood.
We assessed whether delayed clamping of the umbilical cord reduces mortality or major …
We assessed whether delayed clamping of the umbilical cord reduces mortality or major …
The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's …
…, TM Jørgensen, S Rittig, JV Walle, CK Yeung… - The Journal of …, 2006 - auajournals.org
… Infants and young children are unable of indicating these different bladder sensations. A
strong desire to void is probably the only sensation that some children can express. …
strong desire to void is probably the only sensation that some children can express. …
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial …
…, B Turner, A Williams, J Woolmore, C Young… - The Lancet …, 2018 - thelancet.com
Background Although several disease-modifying treatments are available for relapsing multiple
sclerosis, treatment effects have been more modest in progressive multiple sclerosis and …
sclerosis, treatment effects have been more modest in progressive multiple sclerosis and …
Endothelial activation and blood–brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells
…, D Li, D Myerson, LF Gonzalez-Cuyar, C Yeung… - Cancer discovery, 2017 - AACR
Lymphodepletion chemotherapy followed by infusion of CD19-targeted chimeric antigen
receptor–modified T (CAR-T) cells can be complicated by neurologic adverse events (AE) in …
receptor–modified T (CAR-T) cells can be complicated by neurologic adverse events (AE) in …